Menu
Fechar
HRS4R
Vull donar
Firma
JOSEP MARIA SIRVENT-CALVERA
Posició
Cap de Grup - R4
Caps de Grup - R4
Publicacions

Publicacions

Wendel-Garcia PD, Mas A, González-Isern C, Ferrer R, Máñez R, Masclans JR, Sandoval E, Vera P, Trenado J, Fernández R, Sirvent JM, Martínez M, Ibarz M, Garro P, Lopera JL, Bodí M, Yébenes-Reyes JC, Triginer C, Vallverdú I, Baró A, Bodí F, Saludes P, Valencia M, Roche-Campo F, Huerta A, Cambra FJ, Barberà C, Echevarria J, Peñuelas Ó, Mancebo J, UCIsCAT study group

Non-invasive oxygenation support in acutely hypoxemic COVID-19 patients admitted to the ICU: a multicenter observational retrospective study

CRITICAL CARE, 2022, 26, 37-37 dx.doi.org/10.1186/s13054-022-03905-5

Sirvent JM, Baro A, Morales M, Sebastian P, Saiz X

Predictive biomarkers of mortality in critically ill patients with COVID-19.

Medicina Intensiva, 2022, 46, 94-96 dx.doi.org/10.1016/j.medine.2021.11.010
0

Trends in mortality in septic patients according to the different organ failure during 15 years

CRITICAL CARE, 2022, 26, 302-302 dx.doi.org/10.1186/s13054-022-04176-w
0

Dysbiosis: An Indicator of COVID-19 Severity in Critically Ill Patients

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 dx.doi.org/10.3390/ijms232415808
0

Individuals With SARS-CoV-2 Infection During the First and Second Waves in Catalonia, Spain: Retrospective Observational Study Using Daily Updated Data

JMIR Public Health and Surveillance, 2022, 8 dx.doi.org/10.2196/30006

Sirvent JM, Cordon C, Cuenca S, Fuster C, Lorencio C, Ortiz P

Application, verification and correction from an elaborate checklist with some of the recommendations ("do and do not do") of the SEMICYUC working groups

MEDICINA INTENSIVA, 2021, 45, 88-95 dx.doi.org/10.1016/j.medin.2019.07.009

Murcia-Gubianas C, Yébenes JC, Buxó M, Sirvent JM, Pinart E

Dynamics of high-sensitivity troponin T and myocardial dysfunction during the first 72 h of septic shock

EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 91, 104-106 dx.doi.org/10.1016/j.ejim.2021.05.034

Mayneris-Perxachs J, Russo MF, Ramos R, de Hollanda A, Arxé AA, Rottoli M, Arnoriaga-Rodríguez M, Comas-Cufí M, Bartoletti M, Verrastro O, Gudiol C, Fages E, Giménez M, Gil AG, Bernante P, Tinahones F, Carratalà J, Pagotto U, Hernández-Aguado I, Fernández-Aranda F, Meira F, Castro Guardiola A, Mingrone G, Fernández-Real JM, Obesity-T2DM Covid19 Study Group

Blood Hemoglobin Substantially Modulates the Impact of Gender, Morbid Obesity, and Hyperglycemia on COVID-19 Death Risk: A Multicenter Study in Italy and Spain

Frontiers in Endocrinology, 2021, 12, 741248-741248 dx.doi.org/10.3389/fendo.2021.741248

Sirvent JM, Gordo F

Sepsis is important, but there is more

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2018, 36, 532-532 dx.doi.org/10.1016/j.eimc.2018.02.007

Welte T, Dellinger RP, Ebelt H, Ferrer M, Opal SM, Singer M, Vincent JL, Werdan K, Martin-Loeches I, Almirall J, Artigas A, Ignacio Ayestarán J, Nuding S, Ferrer R, Sirgo Rodríguez G, Shankar-Hari M, Álvarez-Lerma F, Riessen R, Sirvent JM, Kluge S, Zacharowski K, Bonastre Mora J, Lapp H, Wöbker G, Achtzehn U, Brealey D, Kempa A, Sánchez García M, Brederlau J, Kochanek M, Reschreiter HP, Wise MP, Belohradsky BH, Bobenhausen I, Dälken B, Dubovy P, Langohr P, Mayer M, Schüttrumpf J, Wartenberg-Demand A, Wippermann U, Wolf D, Torres A

Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)

INTENSIVE CARE MEDICINE, 2018, 44, 438-448 dx.doi.org/10.1007/s00134-018-5143-7

Formulari de contacte

Coneix l’IDIBGI!

 menu